Statera Biopharma, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Statera Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2022.
  • Statera Biopharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$1.55M, a 84% increase year-over-year.
  • Statera Biopharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$88.2M, a 261% decline year-over-year.
  • Statera Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$98.3M, a 836% decline from 2020.
  • Statera Biopharma, Inc. annual Operating Income (Loss) for 2020 was -$10.5M, a 345% decline from 2019.
  • Statera Biopharma, Inc. annual Operating Income (Loss) for 2019 was -$2.36M, a 50.8% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$88.2M -$1.55M +$8.1M +84% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
Q2 2022 -$96.3M -$2.85M +$3.47M +54.9% Apr 1, 2022 Jun 30, 2022 10-Q 2022-10-28
Q1 2022 -$99.8M -$6.61M -$1.42M -27.3% Jan 1, 2022 Mar 31, 2022 10-Q 2022-10-21
Q4 2021 -$98.3M -$77.2M -$73.9M -2243% Oct 1, 2021 Dec 31, 2021 10-K 2022-10-06
Q3 2021 -$24.5M -$9.64M -$3.47M -56.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$21M -$6.32M -$5.73M -968% Apr 1, 2021 Jun 30, 2021 10-Q 2022-10-28
Q1 2021 -$15.3M -$5.19M -$4.75M -1069% Jan 1, 2021 Mar 31, 2021 10-Q 2022-10-21
Q4 2020 -$10.5M -$3.29M -$3.01M -1074% Oct 1, 2020 Dec 31, 2020 10-K 2022-10-06
Q3 2020 -$7.49M -$6.17M -$5.65M -1090% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$1.84M -$592K +$179K +23.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$2.01M -$444K +$346K +43.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$2.36M -$281K +$347K +55.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-22
Q3 2019 -$2.71M -$518K +$749K +59.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$3.46M -$772K +$296K +27.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$3.75M -$790K +$1.05M +57% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$4.8M -$628K +$586K +48.3% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-15
Q3 2018 -$5.39M -$1.27M -$70.4K -5.88% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$5.31M -$1.07M +$502K +32% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$5.82M -$1.84M -$217K -13.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$5.6M -$1.21M +$622K +33.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-07
Q3 2017 -$6.22M -$1.2M -$483K -67.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$5.74M -$1.57M -$76.3K -5.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$5.66M -$1.62M +$693K +30% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$6.36M -$1.84M -$23.6K -1.3% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-06
Q3 2016 -$6.33M -$714K +$2.1M +74.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$8.44M -$1.49M +$1.36M +47.6% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$9.79M -$2.31M +$999K +30.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$10.8M -$1.81M +$1.64M +47.5% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-22
Q3 2015 -$12.4M -$2.82M +$622K +18.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$13.1M -$2.85M +$1.16M +29% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$14.2M -$3.31M +$208K +5.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$14.4M -$3.45M -$455K -15.2% Oct 1, 2014 Dec 31, 2014 10-K 2015-02-27
Q3 2014 -$14M -$3.44M +$2.42M +41.3% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$16.4M -$4.01M +$2.76M +40.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 -$19.1M -$3.52M +$3.93M +52.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$23.1M -$3M +$2.57M +46.1% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-27
Q3 2013 -$25.6M -$5.86M +$1.99M +25.3% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-27
Q2 2013 -$27.6M -$6.78M +$2.39M +26% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-27
Q1 2013 -$30M -$7.45M +$34.4K +0.46% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-27
Q4 2012 -$30M -$5.56M +$843K +13.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-17
Q3 2012 -$30.9M -$7.84M -$880K -12.6% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-17
Q2 2012 -$30M -$9.16M -$2.53M -38.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-17
Q1 2012 -$27.5M -$7.48M -$2.37M -46.4% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-17
Q4 2011 -$25.1M -$6.4M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-17
Q3 2011 -$6.96M -$5.99M -619% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$6.63M -$4.01M -153% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$5.11M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-07
Q3 2010 -$968K Jul 1, 2010 Sep 30, 2010 10-Q/A 2011-11-14
Q2 2010 -$2.62M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.